DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	13.66T
Revenue (ttm)	4.82T
Net Income (ttm)	796.24B
Shares Out	130.75M
EPS (ttm)	6,089.52
PE Ratio	17.16
Forward PE	15.72
Dividend	7,500.00 (7.18%)
Ex-Dividend Date	Dec 24, 2024

Volume	19,946
Average Volume	29,517
Open	106,000
Previous Close	105,800
Day's Range	103,800 - 106,500
52-Week Range	87,000 - 125,900
Beta	0.37
RSI	64.73
Earnings Date	Apr 18, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.